United States

Texas

Name of AuthorInstitutional Affiliation
Borthakur GDepartment of Leukemia, M.D. Anderson Cancer Center, Houston, TX 77030, USA. gborthak@mdanderson.org
Bueso-Ramos CDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Cripe LDDepartment of Medicine, Scott and White Hospital, Temple, Texas 76508, USA.
Ferrajoli AUniversity of Texas MD Anderson Cancer Center, Department of Leukemia, Unit 428, PO Box 301402, Houston, TX 77230-1402, USA. aferrajo@mdanderson.org
Frankel AEDepartment of Medicine, Scott and White Hospital, Temple, Texas 76508, USA. afrankel@swmail.sw.org
Gandhi VDepartment of Experimental Therapeutics, Box 71, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. vgandhi@mdanderson.org
Glassman, Armand BDivision of Pathology and Laboratory Medicine, Department of Hematopathology, Section of Cytogenetics, Unit 350, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. aglassma@mdanderson.org
Hayes, Kimberly JDivision of Pathology and Laboratory Medicine, Department of Hematopathology, Section of Cytogenetics, Unit 350, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
Kantarjian, HagopDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA.
Keating MDepartment of Leukemia, U.T. MD Anderson Cancer Center, Houston, TX.
Keating MJThe University of Texas M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA.
Keating, MichaelDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA.
Keating, Michael JDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA. wwierda@mdanderson.org
Khouri IFDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Mocarski ESDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston , TX 77030, USA.
O'Brien SDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030;, USA. sobrien@mdanderson.org
O'Brien SMDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
O'brien SDepartment of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4095, USA.
Rai KRM.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030-7305, USA.
Ravandi FDepartment of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4095, USA. fravandi@mdanderson.org
Tsimberidou AMDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. atsimber@mdanderson.org
Wierda WDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. wwierda@mdanderson.org
Wierda WGThe University of Texas M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA. wwierda@mdanderson.org
Wierda, WilliamDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA. wwierda@mdanderson.org
Yee KWDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.